The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker has been expecting this year.

GSK's Blujepa Approved For Treatment of UTIs in Women, Children. Published: March 25, 2025 at 6:40 p.m. ET. Share. ... GSK said. Write to Stephen Nakrosis at stephen.nakrosis@wsj.com.

GSK Plc’s long-acting HIV prevention drug is as safe in pregnant women as daily pills, a boost to the company’s efforts to cement its place in the market for antivirals that patients don’t ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

GSK's Blujepa Approved For Treatment of UTIs in Women, Children Provided by Dow Jones Mar 25, 2025, 10:55:00 PM. By Stephen Nakrosis .

GSK plans U.S. launch in second half of the year GSK expects Blujepa and other drugs to contribute to over £2 billion in peak sales Blujepa's unique action reduces bacterial resistance risk, GSK ...